Zopiclone is Preferred Over Lorazepam for Insomnia
For short-term treatment of insomnia in a typical adult, zopiclone is the better choice compared to lorazepam. While both medications can improve sleep parameters, major clinical guidelines explicitly advise against using benzodiazepines like lorazepam for chronic insomnia due to their unfavorable harm-to-benefit ratio, whereas zopiclone (a nonbenzodiazepine BZRA) receives conditional support 1, 2.
Why Benzodiazepines Like Lorazepam Should Be Avoided
The 2020 VA/DoD guidelines and 2017 American Academy of Sleep Medicine (AASM) guidelines both take clear positions on benzodiazepines for insomnia:
The VA/DoD work group explicitly advised against benzodiazepines for chronic insomnia treatment, stating that "the widely known harms and adverse effects of benzodiazepines...were deemed to substantially outweigh the benefits" 1
Critical safety concerns with lorazepam include:
- Risk for dependency and diversion 1
- Falls and cognitive impairment, particularly in older patients 1
- Hypoventilation in patients with respiratory conditions 1
- Physical dependence with potentially life-threatening withdrawal reactions 3
- Protracted withdrawal syndrome lasting weeks to over 12 months 3
- Abuse, misuse, and addiction potential 3
The FDA labeling for lorazepam carries multiple black box-level warnings about these risks 3.
Why Zopiclone is the Better Option
Nonbenzodiazepine BZRAs like zopiclone demonstrate superior benefit-to-harm profiles:
A systematic review found that nonbenzodiazepine BZRAs (including zopiclone) improved sleep efficiency, sleep onset latency, sleep quality, total sleep time, and wake after sleep onset compared with placebo 1
The VA/DoD guidelines concluded that "benefits seemed to outweigh potential harms" for nonbenzodiazepine BZRAs, in direct contrast to their recommendation against benzodiazepines 1
The AASM guidelines provide weak recommendations for using nonbenzodiazepine agents (eszopiclone, zaleplon, zolpidem) while making no positive recommendation for lorazepam 2
Direct comparison research found zopiclone equally effective as lorazepam for sleep duration and quality, with no difference in cognitive effects 4
Meta-analysis confirmed zopiclone was not inferior to benzodiazepines on efficacy measures 5
Practical Implementation
For your typical adult patient without contraindications:
- Start with zopiclone 3.75-7.5 mg at bedtime as needed for short-term use
- Use the lowest effective dose for the shortest duration to minimize adverse events 1
- Counsel patients about potential risks including rare but serious sleep behaviors (sleepwalking, sleep-driving) 1
- Consider this a bridge therapy while implementing cognitive behavioral therapy for insomnia (CBT-I), which remains first-line treatment
Reserve lorazepam only for:
- Acute anxiety with insomnia (its FDA-approved indication) 3
- Very short-term situational stress (single 2-4 mg dose) 3
- When zopiclone is contraindicated or unavailable
Important Caveats
- Neither medication is appropriate for long-term use beyond 4-6 weeks 2, 6
- Both carry risks of tolerance, dependence, and adverse effects with prolonged use 7, 8
- Avoid in elderly patients due to increased fall risk and cognitive impairment 1
- Contraindicated with respiratory disease (COPD, sleep apnea) 3
- Never combine with opioids or alcohol due to fatal respiratory depression risk 3
The evidence consistently demonstrates that while both medications can induce sleep, zopiclone's more favorable safety profile and guideline support make it the appropriate choice when pharmacotherapy is indicated for insomnia 1, 2.